Resumen

MARTINEZ-CASTRO, Raúl et al. Polycythaemia vera. Gac. Méd. Méx [online]. 2022, vol.158, suppl.3, pp.11-17.  Epub 26-Ago-2025. ISSN 2696-1288.  https://doi.org/10.24875/gmm.m22000664.

Polycythemia vera (PV) is mainly characterized by erythrocytosis, thrombotic and hemorrhagic predisposition, a variety of symptoms, and cumulative risks of fibrotic progression and/or leukemic evolution over time. The diagnosis is made based on the 2016 WHO criteria. The treatment of PV focuses on rapidly reducing the erythrocyte mass, either by means of phlebotomies or with cytoreductive treatment, and the reduction of thrombotic risk by correcting cardiovascular risk factors and the use of platelet antiaggregants.

Palabras llave : Erythrocytosis; Polycythemia vera; Myeloproliferative neoplasms.

        · resumen en Español     · texto en Español     · Español ( pdf )